Archives for June 22, 2004

← 2004

NovaSeptum samplers upgraded

NovAseptic has upgraded its NovaSeptum range of disposable samplers to reduce the level of endotoxins to a level that falls well within strict new guidelines set down by the European Pharmacopoeia.

Superfos sticks with pharma unit

After months of trying to find a partner for its pharmaceutical division, Danish packaging company Superfos has abandoned the plan and will retain the business, reports Phil Taylor.

Novel Alzheimer's drug set for clinical trials

The first clinical trial of a peptide that mimics the cellular adhesion molecule NCAM is due to take place in the UK in the third quarter of this year, bringing a potential new treatment for Alzheimer's disease a step closer, reports Phil Taylor.

NIH scientists' in drug firm deal crackdown

Reforms that demand the public disclosure of industry payments to The National Institute of Health (NIH) employees are to be introduced to crackdown on the violation of existing rules that create a conflict of interest between the scientists' duties...

TekCel acquires Biophile assets

Tekcel, a sample management company for life science research, has acquired assets of Biophile that includes its ultra low temperature (minus 80 degrees C) sample management systems designed for research applications in the drug discovery industry.

Oral delivery for osteoporosis drug

Unigene, which specialises in developing oral versions of injectable drugs, has received a $4 million (€3.3m) milestone payment from pharmaceutical major GlaxoSmithKline for starting clinical trials of an osteoporosis drug.

EMD reagents for TAP's protein system

Merck KGaA subsidiary EMD Biosciences has formed a partnership with The Automation Partnership that will see EMD's products included on the new Piccolo system for recombinant protein production.

New barrier film from Tekni-Plex

Tekni-Plex has launched a new range of thermoformable films for blister packaging that is thin, offers high moisture barrier properties and can do away with the need to use environmentally-unsound polyvinylchloride (PVC).

Sigma-Aldrich buys Tetrionics

Sigma-Aldrich has boosted its capacity to supply pharmaceutical ingredients with the purchase of Tetrionics, a company with a strong position in the high growth area of high potency and cytotoxic compounds.